Tag: university
-
Biotech to Design Disease-Blocking Drugs, Gains $75M
A new company that says it can stop disease-causing proteins from forming in cells began public operations today, and is raising $75 million in its first venture round.
-
Real World Evidence Shown to Emulate Some Clinical Trials
A study of insurance claims records matching the design of randomized clinical trials shows claims data can in some cases resemble clinical trial results to make causal inferences.
-
Biotech Partners on Synthetic Proteins to Protect Crops
A developer of synthetic antibody-like proteins for protecting crops is collaborating with a global agricultural chemical company on sustainable biologic insect controls.
-
Trial Shows Plant-Based Drug Helps Reduce Vaping
First results of a clinical trial show a drug derived from plants to aid in smoking cessation helps cut the use of e-cigarettes among non-smokers of burning tobacco.
-
Biotech, Undersea Researchers Partner on Carbon Capture Bacteria
A microbiome biotechnology company and an undersea research group are studying microorganisms that thrive in and consume intense carbon dioxide.
-
Cancer Cell Therapy Biotech Launches, Raises $10M
A start-up company with a process for harvesting large quantities of cells that infiltrate and kill solid tumors is raising $10 million in seed venture funds.
-
Investor Backing Nanotech Drug Discovery Advances
A life science venture investor is funding further development of a lower-cost molecular-level drug discovery process using nanoscale synthetic DNA strands.
-
Self-Applied Patch Shown Feasible for Vaccine Delivery
A clinical trial shows a microneedle patch device for vaccine delivery applied by participants to their own arms works as well in the skin as when administered by clinicians.
-
Industry, Academic Labs Detailing ALS Treatment Actions
Researchers from a developer of neurodegenerative disease therapies and university medical center are investigating the precise workings of a promising ALS treatment.
-
Screening Device Company Kicks-Off Type 1 Diabetes Network
A developer of a blood-testing device that screens for kidney disease risks is the first company to join a network to advance new technology for type 1 diabetes.